Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHBY)

27.28
Real-Time Quote
As of 1:09pm ET
 -0.0201 / -0.07%
Today’s Change
27.02
Today|||52-Week Range
35.13
-20.86%
Year-to-Date
Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Ro...
10:03am / Zacks.com - Paid Partner Content
Epizyme Tazemetostat Gets Fast Track Designation in U.S.
Nov 29 / Zacks.com - Paid Partner Content
Merck KGaA (MKGAF) Expands Distribution Deal with Roche
9:29am / Zacks.com - Paid Partner Content
Will Lilly's Solanezumab Setback Weigh on Other Alzheimer's Stocks?
Nov 25 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytr...
7:18am / Zacks.com - Paid Partner Content
J&J Immunotherapy Darzalex OK'd for Label Expansion by FDA
Nov 22 / Zacks.com - Paid Partner Content
MedTech Industry Stock Outlook - December 2016
Dec 01 / Zacks.com - Paid Partner Content
Novartis (NVS) Reports Favorable Data on Enbrel Biosimilar
Nov 21 / Zacks.com - Paid Partner Content
Pfizer's Herceptin Biosimilar Meets Primary Endpoint in Study
Dec 01 / Zacks.com - Paid Partner Content
$13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Mark...
Nov 21 / MotleyFool.com - Paid Partner Content
3 Ways Pacific Biosciences of California Can Rebound in 2017
Dec 01 / MotleyFool.com - Paid Partner Content
Here's Why Immune Design Should Be in Your Portfolio Now
Nov 21 / Zacks.com - Paid Partner Content
3 Ways Organovo Holdings, Inc. Plans to Grow Exponentially for Years to Come
Dec 01 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal
Nov 18 / Zacks.com - Paid Partner Content